NO


What it isEndogenous gaseous signaling molecule; inhaled for persistent pulmonary hypertension of the newborn.
Why this oneInhaled delivery dilates only ventilated lung, improving matching without systemic hypotension.
What limits itRebound pulmonary hypertension on abrupt withdrawal. Methemoglobinemia; nitrogen dioxide formation must be monitored.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypoxic respiratory failure with pulmonary hypertension (term/near-term neonates >34 wk gestation), with ventilatory support | Neonates | 20 ppm inhaled | 20 ppm (doses >20 ppm not recommended) |
Renal Undefined
Hepatic Undefined
Doses >20 ppm not recommended
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 800 ppm | gas | per unit | not offered | |
| 4880 ppm | gas | per unit | not offered |
NO BOXED WARNINGS
Principal riskRebound pulmonary hypertension on abrupt withdrawal
Defining liabilityMethemoglobinemia, NO2 airway injury and rebound pulmonary hypertension